International Consensus Conference on Atopic Dermatitis II (ICCAD II): clinical update and current treatment strategies.
Ellis
C
C
Department of Dermatology, University of Michigan Medical Center, Ann Arbor, MI, U.S.A. cellis@med.umich.edu
Luger
T
T
Abeck
D
D
Allen
R
R
Graham-Brown
R A C
RA
De Prost
Y
Y
Eichenfield
L F
LF
Ferrandiz
C
C
Giannetti
A
A
Hanifin
J
J
Koo
J Y M
JY
Leung
D
D
Lynde
C
C
Ring
J
J
Ruiz-Maldonado
R
R
Saurat
J-H
JH
D000287:Administration, Topical; D017024:Chemotherapy, Adjuvant; D002986:Clinical Trials as Topic; D003876:Dermatitis, Atopic / Q000209:etiology / Q000628:therapy*; D003879:Dermatologic Agents / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D016559:Tacrolimus / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
D003879:Dermatologic Agents; D007166:Immunosuppressive Agents; C117268:pimecrolimus; D016559:Tacrolimus